James O Armitage - Net Worth and Insider Trading
James O Armitage Net Worth
The estimated net worth of James O Armitage is at least $165,350 dollars as of 2024-04-26. James O Armitage is the Director of Tesaro Inc and owns about 1,500 shares of Tesaro Inc (TSRO) stock worth over $112,440. James O Armitage is also the Director of Cardiff Oncology Inc and owns about 13,000 shares of Cardiff Oncology Inc (CRDF) stock worth over $52,910. Details can be seen in James O Armitage's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that James O Armitage has not made any transactions after 2022-09-16 and currently still holds the listed stock(s).
Transaction Summary of James O Armitage
James O Armitage Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James O Armitage owns 2 companies in total, including Cardiff Oncology Inc (CRDF) , and Tesaro Inc (TSRO) .
Click here to see the complete history of James O Armitage’s form 4 insider trades.
Insider Ownership Summary of James O Armitage
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CRDF | Cardiff Oncology Inc | 2022-09-16 | director |
| TSRO | Tesaro Inc | 2019-01-22 | director |
James O Armitage Latest Holdings Summary
James O Armitage currently owns a total of 2 stocks. Among these stocks, James O Armitage owns 1,500 shares of Tesaro Inc (TSRO) as of September 18, 2017, with a value of $112,440 and a weighting of 68%. James O Armitage also owns 13,000 shares of Cardiff Oncology Inc (CRDF) as of September 16, 2022, with a value of $52,910 and a weighting of 32%.
Latest Holdings of James O Armitage
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSRO | Tesaro Inc | 2017-09-18 | 1,500 | 74.96 | 112,440 |
| CRDF | Cardiff Oncology Inc | 2022-09-16 | 13,000 | 4.07 | 52,910 |
Holding Weightings of James O Armitage
James O Armitage Form 4 Trading Tracker
According to the SEC Form 4 filings, James O Armitage has made a total of 0 transactions in Tesaro Inc (TSRO) over the past 5 years. The most-recent trade in Tesaro Inc is the sale of 10,000 shares on September 18, 2017, which brought James O Armitage around $1 Million.
According to the SEC Form 4 filings, James O Armitage has made a total of 3 transactions in Cardiff Oncology Inc (CRDF) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Cardiff Oncology Inc is the acquisition of 13,000 shares on September 16, 2022, which cost James O Armitage around $20,280.
Insider Trading History of James O Armitage
- 1
James O Armitage Trading Performance
GuruFocus tracks the stock performance after each of James O Armitage's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James O Armitage is 62.7%. GuruFocus also compares James O Armitage's trading performance to market benchmark return within the same time period. The performance of stocks bought by James O Armitage within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James O Armitage's insider trading performs compared to the benchmark.
Performance of James O Armitage
Average Return
123.6%
Outperforming Transactions
75%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 3.68 | 62.7 | 255.62 | 123.6 | -6.52 | -11.24 |
| Relative Return to S&P 500(%) | 1.74 | 55.47 | 245.19 | 102.1 | -16.73 | -23.34 |
James O Armitage Ownership Network
Ownership Network List of James O Armitage
Ownership Network Relation of James O Armitage
James O Armitage Owned Company Details
What does Cardiff Oncology Inc do?
Who are the key executives at Cardiff Oncology Inc?
James O Armitage is the director of Cardiff Oncology Inc. Other key executives at Cardiff Oncology Inc include Chief Medical Officer Fairooz Kabbinavar , Chief Scientific Officer Mark Erlander , and Chief Financial Officer James E. Levine .
Cardiff Oncology Inc (CRDF) Insider Trades Summary
Over the past 18 months, James O Armitage made no insider transaction in Cardiff Oncology Inc (CRDF). Other recent insider transactions involving Cardiff Oncology Inc (CRDF) include a net purchase of 52,950 shares made by Gary W Pace , and a net purchase of 10,000 shares made by Mark Erlander .
In summary, during the past 3 months, insiders sold 0 shares of Cardiff Oncology Inc (CRDF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cardiff Oncology Inc (CRDF) were sold and 62,950 shares were bought by its insiders, resulting in a net purchase of 62,950 shares.
Cardiff Oncology Inc (CRDF)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cardiff Oncology Inc Insider Transactions
James O Armitage Mailing Address
Above is the net worth, insider trading, and ownership report for James O Armitage. You might contact James O Armitage via mailing address: C/o Tesaro, Inc., 1000 Winter St., Suite 3300, Waltham Ma 02451.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
